# Parkinsonian Brain Repair Using Human Stem Cells

> **NCT02780895** · PHASE1 · UNKNOWN · sponsor: **Celavie Bioscences, LLC** · enrollment: 8 (actual)

## Conditions studied

- Idiopathic Parkinson Disease

## Interventions

- **DRUG:** Human Stem Cells

## Key facts

- **NCT ID:** NCT02780895
- **Lead sponsor:** Celavie Bioscences, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2014-05
- **Primary completion:** 2017-12
- **Final completion:** 2018-12
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2016-06-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02780895

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02780895, "Parkinsonian Brain Repair Using Human Stem Cells". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02780895. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*